Intrinsically Magnetic Hydroxyapatite for Scaffold Positioning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current bone and osteocartilage regeneration scaffolds face challenges in controlling cellular differentiation and angiogenesis, as well as the migration and release of growth factors and vascularization factors, which are crucial for osseointegration and tissue healing, often requiring invasive fixing systems and lacking precise control over drug delivery.
Innovation Solution
Intrinsically magnetic hydroxyapatite doped with Fe2+ and Fe3+ ions, which substitutes calcium in the lattice, creating a biocompatible material with magnetic properties that can be guided by external magnetic fields for controlled drug delivery and tissue regeneration, allowing for precise placement and release of biological substances.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If conventional scaffolds are used for bone regeneration, then structural support is provided, but control over cellular differentiation and drug delivery is difficult
Solution Approach 1:
The patent applies parameter changes by doping hydroxyapatite with iron ions (Fe2+ and Fe3+) to alter its magnetic properties. This allows the material to respond to external magnetic fields, enabling control over drug delivery and cellular differentiation without increasing system complexity. The magnetic susceptibility is modified at the material level rather than requiring external control systems.
Solution Approach 2:
The patent replaces mechanical control systems with magnetic field control. Instead of using invasive fixing systems or complex mechanical delivery mechanisms, the invention uses external magnetic fields to guide the migration of growth factors and control drug release from the scaffold, simplifying the overall system while improving ease of operation.
2Reliability
If invasive fixing systems are used to constrain prostheses, then stable positioning is achieved, but patient comfort decreases and surgical complexity increases
Solution Approach 1:
The patent replaces mechanical fixing systems with magnetic field-based positioning. The hydroxyapatite scaffold can be non-invasively constrained in the desired position using external magnetic fields, eliminating the need for invasive fixing systems while maintaining stable positioning. This reduces surgical complexity and improves patient comfort.
3Reliability
If magnetic ions are doped into hydroxyapatite, then magnetic properties are achieved, but crystal structure stability may be compromised
Solution Approach 1:
The patent carefully controls the doping parameters by using specific ratios of Fe2+ to Fe3+ ions and controlling the doping concentration. This allows achieving the desired magnetic properties while maintaining the stability of the hydroxyapatite crystal lattice. The parameter optimization ensures that magnetic functionality is achieved without compromising structural integrity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The intrinsically magnetic hydroxyapatite enables controlled and selective release of biological substances, enhances biocompatibility, and allows for non-invasive manipulation of bone and osteocartilage regeneration scaffolds, improving osseointegration and tissue healing by applying external magnetic fields, thus overcoming the limitations of existing systems.
Implementation Method 1
Intrinsically magnetic hydroxyapatite doped with Fe2+ and Fe3+ ions, which substitutes calcium in the lattice, creating a biocompatible material with magnetic properties that can be guided by external magnetic fields
Data Source
AI summary
The present invention relates to hydroxyapatite doped with Fe2+ ions and Fe3+ ions which partially substitute the calcium ions in the crystal lattice. The hydroxyapatite is characterized by an intrinsic magnetism of 0.05 to 8 emu/g, measured by applying a magnetic field of 34 Oe, due to the presence of magnetic nano-domains in the crystal lattice of HA, given the limited amount of magnetic secondary phases present, less than about 3% by volume. The intrinsically magnetic hydroxyapatite can be loaded with biological substances selected in the group consisting of proteins, genes, stem cells, growth factors, vascularization factors, active substances and drugs, under the control of an external magnetic field, as a carrier and release agent for biological substances or drugs, as a contrast agent in diagnostics or for bone or osteocartilage regeneration.